A Decade of Strides in Personalized Medicine and Digital Health

Progress and transformation–are two words we definitely want to be associated with our US Healthcare. 

Today’s guest, Beth Davis, addresses the significant strides made in digital healthcare and smart technologies, ranging from wearable devices to implantable devices that monitor vital signs and manage chronic conditions like diabetes. She emphasizes the positive impact on test turnaround time, treatment plans, and patient care management facilitated by advancements in biomarkers, diagnostic platforms, and gene sequencing.

The conversation also explores challenges that persist, particularly in the regulatory pathway and the complexities of securing funding for emerging technologies. The lengthy and uncertain timeline for test coverage and reimbursement is a factor, shedding light on the financial burden faced by companies bringing new technologies to market.

Other topics discussed include:

• Common mistakes made by companies when launching novel diagnostic tests in the U.S. &  the importance of a well-thought-out reimbursement and market access strategy from the concept phase
• The evolving relationship between the healthcare industry and health plans, and the collaborative efforts and direct dialogue between manufacturers and payers that are needed

Join us for this eye-opening discussion, and if you’re a laboratory professional helping bring forward diagnostic tests, AND have interest in being a guest on this show, please DM Perry on Linkedin. 

—----

Stay connected with our host, Perry Dimas, here on LinkedIn!